1-(2-Chlorophenyl)-3-(6-methyl-4-oxo-1,4-dihydropyrimidin-2-yl)guanidine

Catalog No.: 
ACTYED169
CAS No.: 
857413-65-1
Molecular Formula: 
C12H12ClN5O
Molecular Weight: 
277.71
1-(2-Chlorophenyl)-3-(6-methyl-4-oxo-1,4-dihydropyrimidin-2-yl)guanidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$167.00InquiryInquiry
5g97%$818.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(2-Chlorophenyl)-3-(6-methyl-4-oxo-1,4-dihydropyrimidin-2-yl)guanidine
IUPAC Name1-(2-chlorophenyl)-3-(6-methyl-4-oxo-1,4-dihydropyrimidin-2-yl)guanidine
MDL No.MFCD19103553
Molecular FormulaC12H12ClN5O
Molecular Weight277.71
SMILESCC1=CC(=O)N=C(NC(=N)NC2=CC=CC=C2Cl)N1
InChI KeyOHDLATVYLRNVPG-UHFFFAOYSA-N
SynonymN-(2-Chlorophenyl)-N'-(6-methyl-4-oxo-1,4-dihydropyrimidin-2-yl)guanidine;1-(2-Chlorophenyl)-3-(6-methyl-4-oxo-1,4-dihydropyrimidin-2-yl)guanidine
CAS No.857413-65-1

Synthetic Route by SureRoute

1. ACTYED169 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQBMC283 route compound structure diagram
    ACQBMC2833977-29-5In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTYED169 route product structure diagram
    ACTYED169857413-65-1
Inquiry

2. ACTYED169 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQBMC283 route compound structure diagram
    ACQBMC2833977-29-5In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTYED169 route product structure diagram
    ACTYED169857413-65-1
Inquiry

3. ACTYED169 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTYED169 route product structure diagram
    ACTYED169857413-65-1
Inquiry

Comments (0)